Vice President, Clinical Development – Oncology

🕒 Julho 27

🏄 California – Remoto

🏄 California – Remote

💵 $360.000 - $425.000 / ano

⏰ Tempo Integral

🔴 Especialista

👔 Vice-presidente

👻 Score fantasma 23%

O que significa: quão provável esta vaga está aberta sem contratação ativa.Como ler: 60% ou mais significa que achamos que é uma vaga fantasma. Pontuações mais baixas preocupam menos.Como pontuamos: tempo em aberto, republicações, vagas abertas vs tamanho do time, rapidez para fechar vagas, e se o salário está divulgado.Observação: é uma estimativa de dados públicos, não um julgamento da empresa. Vagas reais podem ter pontuação alta, então use como uma dica, não como um fato.

Candidatar-se

Encontrar Vagas Remotas Similares

Configurar Alerta de Email para Novas Vagas

📊 Verifique sua pontuação de currículo para esta vaga

Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

Enviar Currículo

Allogene Therapeutics

SiteLinkedInTodas as Vagas

201 - 500 funcionários

Fundada em 2017

🧬 Biotecnologia

💊 Farmacêutico

Biotechnology • Pharmaceuticals

A Allogene Therapeutics é uma empresa de biotecnologia em estágio clínico, com sede em South San Francisco, que desenvolve terapias de células T com receptor de antígeno quimérico alogênico (AlloCAR T) para câncer e doenças autoimunes. A empresa foca em imunoterapia e oncologia, aproveitando abordagens de CAR T prontos para uso a fim de criar produtos de terapia celular alogênica direcionados a malignidades hematológicas e, potencialmente, a indicações autoimunes.

Descrição

• Lead the Oncology Clinical Development team, ensuring that the performance of employees is proactively managed and they are coached, trained and developed in order to maximize their contribution • Accountable for the company’s oncology clinical development including clinical trials execution and data collection and analysis • Responsible for development of clinical protocols to support the company’s product strategy, data collection and management and final reports development in compliance with appropriate standard operating procedures, regulatory and medical standards • Collaborate with our head of medical affairs around scientific communication of our clinical data and execution of oncology congress planning and representation and advisory boards • Key member and/or leader of the oncology asset teams in which asset strategy is developed and its execution is overseen • Represent oncology clinical development at senior executive meetings • Identification and communication around opportunities for change and alignment and leadership toward change when necessary • Influence and/or develop broad-based programs and initiatives to meet executive level vision and mission • Collaborate with functional leaders to set strategy and shared objectives and interactions with health agencies and vendors (including CROs) • Represent Allogene at meetings with regulatory authorities and third parties such as licensing or co-development partners, consultants, etc. • Other duties as assigned

🎯 Requisitos

• MD; completion of residency and oncology fellowship with extensive industry leadership experience in developing oncology treatments experience required; cell therapy experience is highly desirable • Global experience in clinical trial as well as post-marketing setting (cell therapy experience highly preferred but not required) • Strong knowledge and understanding of US, EU and Asian development requirements and general regulatory expectations • Ability to evaluate and manage CROs and other vendors • Excellent organizational skills and an ability to prioritize effectively to deliver results within aggressive timelines with the ability to work independently and as part of a team • Strong interpersonal skills including verbal and written communication are essential in this collaborative work environment • Ability to communicate with internal and external physicians to evaluate specific safety events • Candidates must be authorized to work in the U.S

🏖️ Benefícios

• Annual performance bonus • Equity • Health insurance • Generous time off (including 2 annual holiday company-wide shutdowns)